|
Angiotensin II Clinical Trials
3 actively recruiting trials across 2 locations
Also known as: Giapreza (synthetic human angiotensin II)
Pipeline
Phase 3: 1Phase 4: 1Phase 2/3: 1
Top Sponsors
- Universität Münster1
- University of Maryland St. Joseph Medical Center1
- University of California, San Francisco1
Indications
- Vasoplegia2
- Heart Disease2
- Vasodilatory Hypotension During or After Cardiac Surgery1
- Cardiac Surgery1
- Liver Disease1
Other1 trial
San Francisco, California1 trial
Angiotensin II in Liver Transplantation
University of California, San Francisco
Phase 2/3
Towson, Maryland1 trial
ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)
University of Maryland St. Joseph Medical Center
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.